GlassScriptPhysician profile
Stephen D Covington
NPI 1154353456
$965.81
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $154 · 2021: $251 · 2022: $417 · 2023: $14.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $456.75 | 2019-2022 | |
| Janssen Biotech, INC. | $123.25 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $107.08 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $66.61 | 2019-2022 | |
| Celgene Corporation | $34.07 | 2021-2022 | |
| Pfizer INC. | $33.58 | 2019-2022 | |
| Redhill Biopharma INC. | $23.99 | 2022 | |
| Allergan, INC. | $21.78 | 2019 | |
| Gilead Sciences, INC. | $20.83 | 2019 | |
| Ironwood Pharmaceuticals, INC | $18.45 | 2022 | |
| Alexion Pharmaceuticals, INC. | $18.36 | 2022 | |
| Intercept Pharmaceuticals, INC. | $15.86 | 2019 | |
| Novo Nordisk INC | $14.09 | 2023 | |
| Alfasigma USA, INC. | $11.11 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Covington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.